FLUTICASONE FUROATE TEVA 27,5 microgrammes/pulvérisation, suspension pour pulvérisation nasale — 1 flacon en verre brun de 10,4 g (correspondant à 120 pulvérisations) de suspension avec pompe doseuse et pulvérisateur nasal
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400930293324 -
CIP7
3029332 -
CIS
66160831
What the source publishes
- Holder
- TEVA (PAYS-BAS)
- Active ingredients
- FUROATE DE FLUTICASONE
- Form
- suspension pour pulvérisation
- Package
- 1 flacon en verre brun de 10,4 g (correspondant à 120 pulvérisations) de suspension avec pompe doseuse et pulvérisateur nasal
- Routes
- nasale
- Administrative status
- authorised
- Supply regime
- liste I
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2024-04-10
- Prescription
- Prescription or restricted
Names this record is found by
- FLUTICASONE FUROATE TEVA 27,5 microgrammes/pulvérisation, suspension pour pulvérisation nasale — 1 flacon en verre brun de 10,4 g (correspondant à 120 pulvérisations) de suspension avec pompe doseuse et pulvérisateur nasal
- FLUTICASONE FUROATE TEVA 27,5 microgrammes/pulvérisation, suspension pour pulvérisation nasale
- FUROATE DE FLUTICASONE
Complete source data
{
"cis": "66160831",
"cip7": "3029332",
"form": "suspension pour pulvérisation",
"name": "FLUTICASONE FUROATE TEVA 27,5 microgrammes/pulvérisation, suspension pour pulvérisation nasale — 1 flacon en verre brun de 10,4 g (correspondant à 120 pulvérisations) de suspension avec pompe doseuse et pulvérisateur nasal",
"cip13": "3400930293324",
"holder": "TEVA (PAYS-BAS)",
"routes": [
"nasale"
],
"holders": [
"TEVA (PAYS-BAS)"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "4.90",
"authorisedOn": "2024-04-10",
"compositions": [
{
"name": "FUROATE DE FLUTICASONE",
"nature": "SA",
"strength": "27,5 microgrammes",
"linkageNumber": "1",
"substanceCode": "60723",
"dosageReference": "une pulvérisation délivrée",
"pharmaceuticalElement": "suspension"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "liste I",
"dispensingFee": "1.02",
"medicinePrice": "3.88",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "FLUTICASONE FUROATE TEVA 27,5 microgrammes/pulvérisation, suspension pour pulvérisation nasale",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "1 flacon en verre brun de 10,4 g (correspondant à 120 pulvérisations) de suspension avec pompe doseuse et pulvérisateur nasal",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"30%"
],
"marketingDeclaredOn": "2025-01-13",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"FUROATE DE FLUTICASONE"
],
"authorisationProcedure": "Procédure décentralisée",
"prescriptionConditions": [
"liste I"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": null,
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400930293324"